Related Experiment Videos
Mitochondrial cardiomyopathy with involvement of skeletal muscles
Insights
This study details a rare infantile cardiomyopathy caused by abnormal mitochondria (mitochondriopathy) and myofibril loss in heart muscle. The exact cause remains unknown, but it may stem from a functional mitochondrial defect.
Area of Science:
- Cardiovascular Pathology
- Mitochondrial Biology
- Pediatric Cardiology
Background:
- Idiopathic hypertrophic cardiomyopathy (IHC) is a complex cardiac condition.
- Infantile cardiomyopathy presents unique diagnostic challenges.
- Mitochondrial dysfunction can impact various organ systems, including the heart and skeletal muscle.
Observation:
- A case of fatal idiopathic hypertrophic cardiomyopathy in a 21-month-old infant girl is presented.
- Fine structural analysis revealed extreme mitochondrial abnormalities and myofibril loss in cardiac myocytes.
- Mitochondrial hyperplasia was also noted in skeletal muscles.
Findings:
- The infant's cardiomyopathy was characterized by severe mitochondrial hyperplasia and myofibrillar disarray.
- The observed mitochondrial changes suggest a potential mitochondriopathy affecting both cardiac and skeletal muscle.
- The pathogenesis of this condition is currently unknown, possibly linked to a functional mitochondrial defect.
Implications:
- This case highlights a rare infantile cardiomyopathy with distinct ultrastructural features.
- Distinguishing this mitochondriopathy from other infantile cardiomyopathies and myopathies is crucial for diagnosis.
- Further research is needed to elucidate the precise etiology and mechanisms of this rare condition.
Abstract:
In this report we describe an idiopathic hypertrophic cardiomyopathy in a 21 month old infant girl; who died shortly after a small surgical intervention for cardiovascular failure. Fine structural investigation disclosed an extreme increase of often abnormally structured and enlarged mitochondria and a great loss of myofibrils in the heart muscle cells. Furthermore, mitochondrial hyperplasia was observed focally in all skeletal muscles investigated. The pathogenesis of this mitochondriopathy in heart and skeletal muscle is unknown. It might be a consequence of a functional mitochondrial defect with compensatory hyperplasia of mitochondria. Differential diagnosis of this very rare infantile cardiomyopathy from the myopathies of storage diseases, typical hypertrophic cardiomyopathy and carnitine defiency is discussed, as is the distinction from the oncocytic or so-called histiocytic transformation of heart muscle cells. Methological hints for diagnostic procedures are given.